You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12–24 months
|
|---|---|
| Published in |
Malaria Journal, July 2009
|
| DOI | 10.1186/1475-2875-8-163 |
| Pubmed ID | |
| Authors |
John PA Lusingu, Samwel Gesase, Salum Msham, Filbert Francis, Martha Lemnge, Misago Seth, Samwel Sembuche, Acleus Rutta, Daniel Minja, Method D Segeja, Samuel Bosomprah, Simon Cousens, Ramadhani Noor, Roma Chilengi, Pierre Druilhe |
| Abstract |
Development and deployment of an effective malaria vaccine would complement existing malaria control measures. A blood stage malaria vaccine candidate, Merozoite Surface Protein-3 (MSP3), produced as a long synthetic peptide, has been shown to be safe in non-immune and semi-immune adults. A phase Ib dose-escalating study was conducted to assess the vaccine's safety and immunogenicity in children aged 12 to 24 months in Korogwe, Tanzania (ClinicalTrials.gov number: NCT00469651). |
Mendeley readers
The data shown below were compiled from readership statistics for 83 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 1% |
| India | 1 | 1% |
| France | 1 | 1% |
| Unknown | 80 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 15 | 18% |
| Student > Ph. D. Student | 14 | 17% |
| Researcher | 10 | 12% |
| Student > Bachelor | 9 | 11% |
| Student > Doctoral Student | 3 | 4% |
| Other | 11 | 13% |
| Unknown | 21 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 22 | 27% |
| Agricultural and Biological Sciences | 14 | 17% |
| Immunology and Microbiology | 6 | 7% |
| Nursing and Health Professions | 5 | 6% |
| Social Sciences | 3 | 4% |
| Other | 10 | 12% |
| Unknown | 23 | 28% |